Advancing the field of drug delivery: Taking aim at cancer

被引:257
作者
Moses, MA
Brem, H
Langer, R
机构
[1] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[2] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S1535-6108(03)00276-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Drug delivery systems for cancer therapeutics have now been used by millions of patients and have resulted in the creation of new therapies as well as significantly improving existing ones. Here we discuss a number of the drug delivery systems that have been approved by regulatory authorities and that are currently in clinical use, such as controlled delivery of cancer therapeutics, local chemotherapy, polymer drug conjugates, liposomal systems, and transdermal drug delivery patches. The next generation of "smart" drug delivery approaches such as controlled release microchips are discussed as are some of the future challenges and directions in this field.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 35 条
[31]   A controlled-release microchip [J].
Santini, JT ;
Cima, MJ ;
Langer, R .
NATURE, 1999, 397 (6717) :335-338
[32]   An eight-month clinical study of LA-2575 30.0 mg: A new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer [J].
Sartor, O ;
Dineen, MK ;
Perez-Marreno, R ;
Chu, FM ;
Carron, GJ ;
Tyler, RC .
UROLOGY, 2003, 62 (02) :319-323
[33]   Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study [J].
Valtonen, S ;
Timonen, U ;
Toivanen, P ;
Kalimo, H ;
Kivipelto, L ;
Heiskanen, O ;
Unsgaard, G ;
Kuurne, T .
NEUROSURGERY, 1997, 41 (01) :44-48
[34]   THE ROLE OF MINOCYCLINE IN THE TREATMENT OF INTRACRANIAL 9L GLIOMA [J].
WEINGART, JD ;
SIPOS, EP ;
BREM, H .
JOURNAL OF NEUROSURGERY, 1995, 82 (04) :635-640
[35]   A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma [J].
Westphal, M ;
Hilt, DC ;
Bortey, E ;
Delavault, P ;
Olivares, R ;
Warnke, PC ;
Whittle, IR ;
Jääskeläinen, J ;
Ram, Z .
NEURO-ONCOLOGY, 2003, 5 (02) :79-88